BriaPro Therapeutics Corp. Deal History & Licensing Activity
BriaPro Therapeutics Corp. is a life sciences. Over the past three years, BriaPro Therapeutics Corp. has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Oncology
BriaPro Therapeutics Corp. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving BriaPro Therapeutics Corp. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Soluble CD80 | BriaCell Therapeutics Corp. | Other | Preclinical | acquisition | Feb 2026 |
BriaPro Therapeutics Corp. Pipeline Focus
Therapeutic areas and modalities where BriaPro Therapeutics Corp. is most active based on deal history and clinical trial data.
BriaPro Therapeutics Corp. Strategic Signals
Key indicators of BriaPro Therapeutics Corp.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches BriaPro Therapeutics Corp.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About BriaPro Therapeutics Corp. Licensing & Deal Activity
BriaPro Therapeutics Corp. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, BriaPro Therapeutics Corp. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for BriaPro Therapeutics Corp. include Oncology (2 deals and trials). In terms of modality, BriaPro Therapeutics Corp. has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for BriaPro Therapeutics Corp. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against BriaPro Therapeutics Corp.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.